Casa gordon hayward sofascore

CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2

Por um escritor misterioso

Last updated 08 novembro 2024

CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2

Cells, Free Full-Text

Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein

Smoking and SARS-CoV-2 Impair Dendritic Cells and Regulate DC-SIGN Expression in Tissues

A bird's eye view on the role of dendritic cells in SARS‐CoV‐2 infection: Perspectives for immune‐based vaccines - Galati - 2022 - Allergy - Wiley Online Library

The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies: Molecular Therapy

CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 and are differentially expressed in lung and kidney epithelial and endothelial cells

DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist

Proteomic landscape of SARS-CoV-2– and MERS-CoV–infected primary human renal epithelial cells

Biology, Free Full-Text

Frontiers The role of DC-SIGN as a trans-receptor in infection by MERS-CoV

CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus

SARS-CoV-2 Receptors and Their Involvement in Cell Infection

Full article: Immunouniverse of SARS-CoV-2

Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases, Cell Communication and Signaling

Cellular host factors for SARS-CoV-2 infection

Recomendado para você